Preoperative glycemic control and postoperative clinical outcomes in patients with type 2 diabetes mellitus undergoing bariatric surgery
Clinical Nutrition ESPEN · 2025
DOI: 10.1016/j.clnesp.2025.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition ESPEN, 2025. Verfasst von Bárbara Brambilla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycemic Control, Bariatric Surgery, Blood Glucose. Die Arbeit nennt 35 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: The preoperative glycated hemoglobin (HbA1c) cutoff point for elective surgery in patients with type 2 diabetes mellitus (T2DM) remains unclear, as does its association with postoperative outcomes, especially in patients undergoing bariatric surgery. METHODS: We conducted a retrospective cohort study including patients with T2DM and an electronic record of HbA1c within the four months prior to surgery who underwent Roux-en-Y gastric bypass (RYGB) from August 2010 to May 2019. The primary outcome was postoperative hospital length of stay (LOS), and secondary outcomes included need for intensive care, clinical outcomes (pulmonary, cardiovascular, septic), and surgical wound complications. These outcomes were assessed using an HbA1c cutoff value of 7 %. Comparisons were made using the Mann-Whitney U test and a general linear model adjusting the primary outcome for confounders and for differences in baseline characteristics between groups. RESULTS: A total of 114 individuals were divided into two groups according to HbA1c: ≤7 % (N = 63) or > 7 % (N = 51). No differences were observed between the groups in terms of LOS (4 vs 5 days, p = 0.28) and clinical or operative wound complication rates. Alternative HbA1c cutoff points (7.5 %, 8 %, and 8.5 %) were also evaluated for LOS, with no change in results. CONCLUSION: Bariatric surgery should not be postponed in patients with T2DM based on an HbA1c greater than 7 %, as LOS, clinical outcomes and operative wound complication rates are not worse in patients with poorer glucose control based on this criterion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
- Postgraduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Postgraduate Program in Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
- Internal Medicine Division, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
- Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Postgraduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: bschaan@hcpa.edu.…
Zitieren
APA
Brambilla, B., Blume, C. A., Rosa de Carvalho, T., Alessi, J., & Schaan, B. D. (2025). Preoperative glycemic control and postoperative clinical outcomes in patients with type 2 diabetes mellitus undergoing bariatric surgery. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2025.02.016
Vancouver
Brambilla B, Blume CA, Rosa de Carvalho T, Alessi J, Schaan BD. Preoperative glycemic control and postoperative clinical outcomes in patients with type 2 diabetes mellitus undergoing bariatric surgery. Clinical Nutrition ESPEN. 2025. doi:10.1016/j.clnesp.2025.02.016
BibTeX
@article{Brambilla2025,
author = {Brambilla, Bárbara and Blume, Carina Andriatta and Rosa de Carvalho, Taíse and Alessi, Janine and Schaan, Beatriz D},
title = {Preoperative glycemic control and postoperative clinical outcomes in patients with type 2 diabetes mellitus undergoing bariatric surgery},
journal = {Clinical Nutrition ESPEN},
year = {2025},
doi = {10.1016/j.clnesp.2025.02.016}
}
EUVIMED